FDA Talk Papers are prepared by the Press Office to guide FDA personnel
in responding with consistency and accuracy to questions from the public on
subjects of current interest. Talk Papers are subject to change as more
information becomes available.
T01-12 |
Print Media: 301-827-6242 |
April 9, 2001 |
Consumer Inquiries: 888-INFO-FDA |
FDA's BUDGET REQUEST FOR FY 2002
The President's budget request for the Food and Drug Administration in fiscal
year (FY) 2002 (10/1/2001-9/30/2002) totals $1.414 billion, an increase of $123
million or 9.5% over FY 2001. The budget request, which includes $204 million
in industry-specific user fees, reflects FDA's commitment to continue strengthening
the public health protection by focusing on urgent public health hazards and
major performance goals emphasized by Congress. Here is the breakdown of the
requested appropriations increase:
- $40 million to meet mandated cost-of-living and pay-related increases for
FDA's employees. In the last eight years, FDA has had to absorb $284 million
in unfunded pay raises and other inflationary costs.
- $15 million to protect consumers against the new variant Creutzfeldt-Jakob
Disease, a fatal illness associated with consumption of meat from cows with
Bovine Spongiform Encephalopathy (BSE). The request is earmarked for special
measures to keep BSE, the "Mad Cow Disease," out of the United States.
- $25 million ($10.3 million in budget authority and $14.7 million in new
import user fees) to prevent substandard food and health care products from
reaching the U.S. market by increasing plant inspections and expanding surveillance
of regulated imports;
- $10 million to safeguard patients against adverse events associated with
the use of drugs, biological agents and medical devices by improving FDA's
system for monitoring marketed products;
- $10 million to protect the human subjects and research data in clinical
trials by increasing FDA's inspections.
- $14.7 million ($9.4 million in budget authority and $5.3 million in new
user fees) to significantly upgrade food safety by expanding the highly successful
Food Safety Initiative beyond microbiological contaminants to cover chemical
and physical food hazards; and $17.3 million to enhance FDA's scientific potential
and operational efficiency through infrastructure improvements. The request
includes the development of an advanced financial management system, the completion
of a new laboratory in Los Angeles, and the move of a FDA center to a new
facility in a suburb of Washington, D.C.
FDA is also requesting new user fees -- $15 million for import activities and
$5 million to provide certifications for food exporters -- and several increases
in current user fees, including $12 million (of the total $162 million) requested
for drug and biologic reviews under the Prescription Drug User Fee Act of 1992.
For further information, see the
FDA Backgrounder on the budget request for FY 2002.
FDA News Page
| FDA Home Page
Office of Public Affairs
Web page created by tg 2001-APR-09.